Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
ConflictofInterest
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 35,2026 No.2
The title
The title
The keywords
The author
New Online
Vol 35,2026
Vol 34,2025
Vol 33,2024
Vol 32,2023
No.2
No.1
Contents
Vol 35,2026 No.2
Date of publication: February 15, 2026
Get cover
Get contents
Prev
Vol 35,2026 No.1
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (14): research designs and case studies of target trial emulation
ZHAO Houyu
CHENG Yinchu
SUN Feng
ZHAN Siyan
2026,35(2):121-132
Target trial emulation
Pharmacoepidemiology
Methodology
Guidelines
Active comparator new-user design
Sequential trial
Clone-censor-weight
Details
Download
Mobile
Efficacy of Tangganjian pills and semaglutide on patients with type 2 diabetes and obesity and its impacts on intestinal mucosal barrier function and serum kisspeptin
HU Lijuan
ZHU Hao
WAN Jing
2026,35(2):133-139
Tangganjian pill
Semaglutide
Type 2 diabetes
Obesity
Intestinal mucosal barrier function
Kisspeptin
Details
Download
Mobile
Effects of denosumab versus zoledronic acid on bone formation markers and cancer pain intensity in patients with non-small cell lung cancer and bone metastases: a retrospective study
HU Ran
LI Wei
LI Yonghong
CHEN Cong
WAN Chao
2026,35(2):140-146
Denosumab
Zoledronic acid
Non-small cell lung cancer
Bone metastases
Cancer pain
Bone formation markers
Retrospective study
Details
Download
Mobile
A survey of the current status of tetanus passive immunization agent application in children's hospitals
LIN Jinxiang
CHEN Yushuang
KE Huichao
WANG Jing
ZHANG Qingchi
2026,35(2):147-155
Tetanus
Children
Tetanus antitoxin
Human tetanus immunoglobulin
Immunoprophylaxis
Potentially unnecessary use
Details
Download
Mobile
Adverse drug event signal mining of ezetimibe monotherapy and compound preparations based on the FAERS database
HUANG Yan
YU Yang
2026,35(2):156-163
Ezetimibe
Single tablet compound preparation containing ezetimibe
Combination therapy
Adverse drug event
Signal mining
Pharmacovigilance
Details
Download
Mobile
Analysis of disease burden and future trends of chronic hepatitis C among individuals aged ≥50 years in China and globally from 1990 to 2021
CHEN Si
CHEN Guannan
CHEN Qian
ZHAO Wei
2026,35(2):164-172
Chronic hepatitis C
Disease burden
Incidence
Disability-adjusted life years
Details
Download
Mobile
Post-authorisation safety evaluation of extracorporeal blood circuit based on literature and MAUDE database
LI Kaili
ZENG Baoqi
HUANG Ling
WANG Qiping
SUN Feng
2026,35(2):173-181
Extracorporeal blood circuit
Adverse events
Literature search
Signal detection
Product quality
Connection problems
Operational technique
Details
Download
Mobile
Effects of colchicine on high-sensitivity C-reactive protein and other inflammatory markers in patients with coronary atherosclerotic heart disease: a Meta-analysis
HE Shuangcheng
LIU Yuwei
TAN Gao
YUAN Yu
LIU Tao
LIU Xiaoli
2026,35(2):182-191
Colchicine
Coronary atherosclerotic heart disease
High-sensitivity C-reactive protein
Inflammatory markers
Meta-analysis
Details
Download
Mobile
Mepolizumab for refractory chronic rhinosinusitis with nasal polyps: a rapid health technology assessment
GU Shilong
ZHANG Wenjing
GUO Hao
2026,35(2):192-199
Mepolizumab
Refractory chronic rhinosinusitis with nasal polyps
Effectiveness
safety
Cost-effectiveness
Details
Download
Mobile
Research and development progress on herpes zoster vaccine
DENG Ying
YIN Jiakun
TONG Yeqing
2026,35(2):200-208
Herpes zoster
Herpes zoster vaccine
Live attenuated herpes zoster vaccine
Recombinant protein herpes zoster vaccine
Immune response
Details
Download
Mobile
Antimicrobial treatment practices for an elderly patient with acute exacerbation of chronic renal insufficiency complicated with severe infection
XING Baiqian
CHEN Yalei
WANG Genzhu
WANG Xiaoying
LU Nianfang
2026,35(2):209-214
Chronic renal insufficiency
Severe infection
Pneumocystis jirovecii
Staphylococcus aureus
Pharmaceutical care
Details
Download
Mobile
A case analysis of lenvatinib-induced proteinuria renal injury in patient with metastatic hepatocellular carcinoma after liver transplant
ZHENG Xinyi
WANG Xiaohang
SU Yingjie
2026,35(2):215-220
Hepatocellular carcinoma
Post liver transplantation
Bone metastases
Lenvatinib
Proteinuria
Drug-induced renal injury
Pharmaceutical care
Details
Download
Mobile
Rhabdomyolysis induced by concomitant voriconazole and trimethoprim-sulfamethoxazole in a patient with pulmonary fungal infection: a case report
ZHANG Jiajun
WANG Zhen
ZHOU Ying
ZHANG Peng
GONG Xuepeng
2026,35(2):221-226
Voriconazole
Trimethoprim-sulfamethoxazole
Rhabdomyolysis
Adverse drug reaction
Details
Download
Mobile
Iguratimod-induced organizing pneumonia in a patient with rheumatoid arthritis: a case report
CHEN Huan
TANG Pingxiu
MI Jiali
ZHANG Xunyan
YANG Qiang
2026,35(2):227-231
Iguratimod
Organizing pneumonia
Rheumatoid arthritis
Drug-induced lung injury
Details
Download
Mobile
Acute allergic reaction induced by efbemalenograstim alfa: a case report
ZENG Xin
WANG Yaqin
HUANG Yaxuan
LI Juan
2026,35(2):232-236
Efbemalenograstim alfa
Allergy
mNeutropenia
Adverse drug reaction
Details
Download
Mobile
A case report of rhabdomyolysis, liver and kidney dysfunction induced by capecitabine tablets
YANG Saicheng
XIA Xiuyuan
2026,35(2):237-240
Capecitabine
Rhabdomyolysis
Liver dysfunction
Kidney dysfunction
Adverse drug reactions
Details
Download
Mobile